Abstract:Primary breast cancer is the most common malignant tumor in women worldwide, and axillary lymph node metastasis (ALNM) is an important marker of disease progression in patients with breast cancer. The objective of the present study was to analyze the association between contrast‐enhanced ultrasound (CEUS) features and ALNM in primary breast cancer and its predictive value. A total of 120 patients with breast cancer were assigned to the non‐metastatic group (n=70) and metastatic group (n=50). The factors influencing ALNM were explored by multivariate logistic regression analysis. The consistency of CEUS, ordinary ultrasonography and pathological examination in the diagnosis of the ALNM of breast cancer was evaluated by consistency testing. The sensitivity, specificity and consistency rate of CEUS features and ordinary ultrasonography were analyzed by receiver operating characteristic curve and four‐fold table analyses. High enhancement amplitude, centripetal enhancement sequence, increased maximum cortical thickness, high peak intensity and a larger area under the curve of lymph nodes were more commonly found in the metastatic group than in the non‐metastatic group. The lymph node aspect ratio and time to peak were lower in the metastatic group than the non‐metastatic group. The time to peak was a protective factor for ALNM in patients with breast cancer. The sensitivity, specificity and coincidence rate with pathological examination of CEUS in the diagnosis of ALNM were 92.00, 90.00 and 90.83%, while these of ordinary ultrasonography were 76.00, 80.00 and 78.33%, respectively. The consistency test indicated that CEUS and pathological examination were consistent in the diagnosis of ALNM in patients with breast cancer, with a κ value of 0.816, indicating a good consistency. The κ value of ordinary ultrasonography and pathological examination was 0.763, also indicating a good consistency. However, these results indicate that CEUS is more valuable than ordinary ultrasonography in the diagnosis of ALNM in cases of breast cancer. In conclusion, the present study indicates that CEUS features were influencing factors associated with ALNM in patients with breast cancer and may serve as an important reference for the preoperative prediction of ALNM in breast cancer.

A Study on the Contrast-Enhanced Ultrasound of Triple Negative Breast Cancer Tissues

[Application Value of Contrast-Enhanced Ultrasonography for Assessing the High-Risk Population of Hepatic Malignant Tumor].

The qualitative and quantitative features of contrast-enhanced ultrasound in biomarker expression of breast cancer

Value of Scoring by Contrast-Enhanced Ultrasound Combined with Ultrasonic Elastography in Differential Diagnosis of BI-RADS 4 Lesions

[Diagnostic Value of Contrast-Enhanced Ultrasonography in Preoperative T-staging of Gastric Cancer].

Utility of Quantitative Contrast-Enhanced Ultrasound for the Prediction of Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma

Identification Value of Contrast-Enhanced Sonography on Peripheral Pulmonary Cancer

ROLE OF CONTRAST-ENHANCED ULTRASOUND IN THE PRE-OPERATIVE DIAGNOSIS OF CERVICAL LYMPH NODE METASTASIS IN PATIENTS WITH PAPILLARY THYROID CARCINOMA

Correlation Analysis between Expression Profiles of Molecular Markers and Contrast-Enhanced Ultrasound Parameters in Breast Cancer

Association Between Contrast-Enhanced Ultrasound Characteristics and Molecular Subtypes of Breast Cancer.

The application of contrast enhanced ultrasound in non-mass like breast lesions

Contrast enhanced ultrasound of breast cancer

Three-dimensional Contrast-enhanced Ultrasound in Response Assessment for Breast Cancer: A Comparison with Dynamic Contrast-enhanced Magnetic Resonance Imaging and Pathology.

Quantitative Contrast-Enhanced Ultrasound Evaluation of Pathological Complete Response in Patients with Locally Advanced Breast Cancer Receiving Neoadjuvant Chemotherapy

Multiparametric Contrast-Enhanced Ultrasound in Early Prediction of Response to Neoadjuvant Chemotherapy and Recurrence-Free Survival in Breast Cancer

The Differential Diagnostic Value of Contrast-enhanced Ultrasonography in BI-RADSUS 4B Breast Lesions

Value of Contrast-Enhanced Microflow Imaging in Diagnosis of Breast Masses in Comparison with Contrast-Enhanced Ultrasound

The Value of Contrast-Enhanced Ultrasound (CEUS) in Detecting Minute Renal Cell Carcinoma.

Contrast-enhanced Ultrasonography for Early Prediction of Response of Neoadjuvant Chemotherapy in Breast Cancer

Current status and future perspectives of contrast-enhanced ultrasound diagnosis of breast lesions

Association and predictive value of contrast‐enhanced ultrasound features with axillary lymph node metastasis in primary breast cancer